Impact of Venetoclax Treatment Schedule on Hematologic Recovery and Treatment Response in AML Patients Unfit for Intensive Chemotherapy

ABSTRACT:

SUBMITTER: Schupbach A 

PROVIDER: S-EPMC11987944 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature